Annual short term debt:
$1.82B+$860.91M(+89.68%)Summary
- As of today (September 9, 2025), NVO annual short term debt is $1.82 billion, with the most recent change of +$860.91 million (+89.68%) on December 31, 2024.
- During the last 3 years, NVO annual short term debt has fallen by -$271.43 million (-12.97%).
- NVO annual short term debt is now -12.97% below its all-time high of $2.09 billion, reached on December 31, 2021.
Performance
NVO Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$1.88B-$1.36B(-42.00%)Summary
- As of today (September 9, 2025), NVO quarterly short term debt is $1.88 billion, with the most recent change of -$1.36 billion (-42.00%) on June 1, 2025.
- Over the past year, NVO quarterly short term debt has increased by +$1.10 billion (+140.22%).
- NVO quarterly short term debt is now -42.00% below its all-time high of $3.25 billion, reached on March 31, 2025.
Performance
NVO quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NVO Short term debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +89.7% | +140.2% |
3 y3 years | -13.0% | +966.0% |
5 y5 years | +722.4% | +787.1% |
NVO Short term debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.0% | +765.4% | -42.0% | +966.0% |
5 y | 5-year | -13.0% | +765.4% | -42.0% | +966.0% |
alltime | all time | -13.0% | >+9999.0% | -42.0% | >+9999.0% |
NVO Short term debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $1.88B(-42.0%) |
Mar 2025 | - | $3.25B(+78.2%) |
Dec 2024 | $1.82B(+89.7%) | $1.82B(+120.3%) |
Sep 2024 | - | $826.41M(+5.5%) |
Jun 2024 | - | $783.54M(-46.8%) |
Mar 2024 | - | $1.47B(+53.3%) |
Dec 2023 | $959.94M(+356.3%) | $959.94M(+2.2%) |
Sep 2023 | - | $938.92M(+1.9%) |
Jun 2023 | - | $921.49M(+405.1%) |
Mar 2023 | - | $182.45M(-13.3%) |
Dec 2022 | $210.39M(-89.9%) | $210.39M(-12.9%) |
Sep 2022 | - | $241.51M(+36.8%) |
Jun 2022 | - | $176.57M(-15.4%) |
Mar 2022 | - | $208.81M(-90.0%) |
Dec 2021 | $2.09B(+70.6%) | $2.09B(+894.4%) |
Sep 2021 | - | $210.41M(+1.4%) |
Jun 2021 | - | $207.48M(-80.8%) |
Mar 2021 | - | $1.08B(-12.1%) |
Dec 2020 | $1.23B(+453.7%) | $1.23B(+430.2%) |
Sep 2020 | - | $231.26M(+9.0%) |
Jun 2020 | - | $212.18M(+16.0%) |
Mar 2020 | - | $182.92M(-17.4%) |
Dec 2019 | $221.42M(+180.7%) | $221.42M(+7.1%) |
Sep 2019 | - | $206.76M(+8.0%) |
Jun 2019 | - | $191.49M(+14.3%) |
Mar 2019 | - | $167.55M(+112.4%) |
Dec 2018 | $78.89M(-71.1%) | $78.89M(+50.3%) |
Sep 2018 | - | $52.49M(+35.6%) |
Jun 2018 | - | $38.71M(+2.9%) |
Mar 2018 | - | $37.62M(-86.2%) |
Dec 2017 | $273.21M(+741.0%) | $273.21M(+561.5%) |
Sep 2017 | - | $41.30M(-84.0%) |
Jun 2017 | - | $258.18M(+192.8%) |
Mar 2017 | - | $88.17M(+171.4%) |
Dec 2016 | $32.48M(-79.2%) | $32.48M(-52.8%) |
Sep 2016 | - | $68.82M(+13.5%) |
Jun 2016 | - | $60.63M(-2.4%) |
Mar 2016 | - | $62.10M(-60.2%) |
Dec 2015 | $156.19M(+33.5%) | $156.19M(+65.7%) |
Sep 2015 | - | $94.27M(-14.2%) |
Jun 2015 | - | $109.93M(+28.7%) |
Mar 2015 | - | $85.39M(-27.0%) |
Dec 2014 | $117.00M(+194.6%) | $117.00M(+142.8%) |
Sep 2014 | - | $48.20M(-35.4%) |
Jun 2014 | - | $74.56M(-49.8%) |
Mar 2014 | - | $148.42M(+273.8%) |
Dec 2013 | $39.71M(-59.0%) | $39.71M(-67.4%) |
Sep 2013 | - | $121.79M(-6.7%) |
Jun 2013 | - | $130.53M(+10.5%) |
Mar 2013 | - | $118.16M(+22.0%) |
Dec 2012 | $96.84M | $96.84M(-4.6%) |
Sep 2012 | - | $101.47M(+53.2%) |
Jun 2012 | - | $66.23M(-3.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $68.56M(+10.6%) |
Dec 2011 | $321.90M(+202.6%) | $62.00M(-79.7%) |
Sep 2011 | - | $305.08M(+77.3%) |
Jun 2011 | - | $172.03M(-10.3%) |
Mar 2011 | - | $191.85M(+80.3%) |
Dec 2010 | $106.39M(+32.0%) | $106.39M(-42.0%) |
Sep 2010 | - | $183.38M(-65.9%) |
Jun 2010 | - | $537.38M(+185.4%) |
Mar 2010 | - | $188.30M(+133.6%) |
Dec 2009 | $80.60M(-67.6%) | $80.60M(+79.3%) |
Sep 2009 | - | $44.96M(-47.3%) |
Jun 2009 | - | $85.32M(-67.0%) |
Mar 2009 | - | $258.65M(+3.8%) |
Dec 2008 | $249.13M(+213.7%) | $249.13M(+64.4%) |
Sep 2008 | - | $151.55M(+54.9%) |
Jun 2008 | - | $97.81M(-25.6%) |
Mar 2008 | - | $131.53M(+65.6%) |
Dec 2007 | $79.41M(+32.8%) | $79.41M(+173.8%) |
Sep 2007 | - | $29.00M(+64.7%) |
Jun 2007 | - | $17.60M(-49.7%) |
Mar 2007 | - | $35.02M(-41.4%) |
Dec 2006 | $59.79M(-73.8%) | $59.79M(+16.5%) |
Sep 2006 | - | $51.30M(-8.2%) |
Jun 2006 | - | $55.88M(-70.7%) |
Mar 2006 | - | $190.87M(-16.4%) |
Dec 2005 | $228.36M(+146.5%) | $228.36M(+64.4%) |
Sep 2005 | - | $138.94M(+42.5%) |
Jun 2005 | - | $97.48M(+31.8%) |
Mar 2005 | - | $73.97M(-20.2%) |
Dec 2004 | $92.64M(-43.9%) | $92.64M(+27.3%) |
Sep 2004 | - | $72.77M(-11.4%) |
Jun 2004 | - | $82.17M(-37.3%) |
Mar 2004 | - | $131.06M(-20.6%) |
Dec 2003 | $165.17M(+107.3%) | $165.17M(+107.3%) |
Dec 2002 | $79.68M(-18.6%) | $79.68M(-18.6%) |
Dec 2001 | $97.84M(-5.3%) | $97.84M(-5.3%) |
Dec 2000 | $103.27M(-32.9%) | $103.27M(-23.3%) |
Dec 1999 | $153.95M(+6.2%) | $134.70M(-6.9%) |
Dec 1998 | $145.02M(-25.7%) | $144.65M(-26.4%) |
Dec 1997 | $195.11M(-14.7%) | $196.55M(-13.6%) |
Dec 1996 | $228.69M(-12.7%) | $227.43M(+74.0%) |
Dec 1995 | $261.82M(+10.8%) | $130.69M(-45.4%) |
Dec 1994 | $236.30M(+68.0%) | $239.22M(+68.7%) |
Dec 1993 | $140.62M(-11.7%) | $141.82M(-11.0%) |
Dec 1992 | $159.34M(-30.6%) | $159.33M(-30.6%) |
Dec 1991 | $229.49M(-22.9%) | $229.50M(-22.8%) |
Dec 1990 | $297.57M(+8.3%) | $297.39M(+8.7%) |
Dec 1989 | $274.66M(+50.3%) | $273.58M(+49.4%) |
Dec 1988 | $182.69M(+6.7%) | $183.09M(+6.9%) |
Dec 1987 | $171.23M(+1916.5%) | $171.23M(+1916.5%) |
Dec 1986 | $8.49M(+19.7%) | $8.49M(+19.7%) |
Dec 1985 | $7.10M(-91.8%) | $7.10M(-91.8%) |
Dec 1984 | $86.36M | $86.36M |
FAQ
- What is Novo Nordisk A/S annual short term debt?
- What is the all time high annual short term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual short term debt year-on-year change?
- What is Novo Nordisk A/S quarterly short term debt?
- What is the all time high quarterly short term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly short term debt year-on-year change?
What is Novo Nordisk A/S annual short term debt?
The current annual short term debt of NVO is $1.82B
What is the all time high annual short term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual short term debt is $2.09B
What is Novo Nordisk A/S annual short term debt year-on-year change?
Over the past year, NVO annual short term debt has changed by +$860.91M (+89.68%)
What is Novo Nordisk A/S quarterly short term debt?
The current quarterly short term debt of NVO is $1.88B
What is the all time high quarterly short term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly short term debt is $3.25B
What is Novo Nordisk A/S quarterly short term debt year-on-year change?
Over the past year, NVO quarterly short term debt has changed by +$1.10B (+140.22%)